Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uz Leuven
Leuven, Belgium
Dr Philip Van Damme, Doctor of MedicineNot, yet, recruiting
- Umc Utrecht
Utrecht, Netherlands
Prof Leonard Van Den Berg, Doctor of MedicineRecruiting
- Kings College Hospital
London, United Kingdom
Not, yet, recruiting - Royal Hallamshire Hospital
Sheffield, United Kingdom
Not, yet, recruiting
- St Joseph'S Hospital and Medical Center - Barrow Neurological Institute
Phoenix, Arizona, United States
Dr Shafeeq Ladha, Doctor of MedicineNot, yet, recruiting - University of California San Diego Medical Center
San Diego, California, United States
Dr John Ravits, Doctor of MedicineRecruiting - Mayo Clinic in Florida
Jacksonville, Florida, United States
Dr Bjorn Oskarsson, Doctor of MedicineRecruiting - University of Miami School of Science
Miami, Florida, United States
Dr Michael Benatar, Doctor of MedicineNot, yet, recruiting - Sean M. Healey & Amg Center for Als at Massachusetts General Hospital
Boston, Massachusetts, United States
Dr Doreen Ho, Doctor of MedicineRecruiting - Herbert Irving Comprehensive Cancer Center
New York, New York, United States
Dr Neil Schneider, Doctor of MedicineNot, yet, recruiting - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Dr Colin Quinn, Doctor of MedicineRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Dec 2025
- Primary completion
- 15 Oct 2027
- Completion
- 15 Oct 2027
- Last update posted
- 23 Jun 2026
- Registered enrollment
- 12
- Registry id
- NCT07287397
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.